Clinical Trial Update: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

View source ↗

Summary

A completed real-world study evaluating the ELUVIA zotarolimus-eluting stent in femoropopliteal artery lesions, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Artery Disease

Drugs mentioned

• ELUVIA Stent (zotarolimus-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Arterial Occlusive Diseases, Atherosclerosis | Status: COMPLETED | Results posted: 2026-03-31